Thursday, May 13, 2021

1:00 PM to 2:00 PM Eastern Time
12:00 PM to 1:00 PM Central Time
11:00 AM to 12:00 PM Mountain Time
10:00 AM to 11:00 AM Pacific Time

Speakers

Leidy L. Isenalumhe MD, MS
Assistant Member
Malignant Hematology
Director of Clinical Operations
Malignant Hematology
H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL

Program Description

This live webinar will provide an overview of the common blood cancers adolescents and young adult (AYA) experience blood cancers and their treatments. The presentation will focus on managing the short and long-term side effects unique to this population as well as review the importance of following a care plan.

Target Audience

Physicians, advance practice providers, and nurses involved in the care of adolescents and young adults with hematologic malignancies.

Provider

The Leukemia & Lymphoma Society and Clinical Directors Network, Inc. 

Learning Objectives

At the conclusion of this program, participants will be able to:

• Describe common adolescent and young adult (AYA) blood cancers

• Identify signs and symptoms of AYA blood cancer and diagnostic tests

• Explain treatments, including the role of clinical trials

• Discuss management of short- and long-term effects, including fertility challenges

• Address unique considerations for AYAs (e.g., sexuality and intimacy, finances, and health insurance)

• Discuss strategies to enhance provider communication with AYAs to help them navigate challenges

Accreditation Statement

The Treating Adolescents and Young Adults with Blood Cancer program is approved for up to 1.0 prescribed credit by the American Academy of Family Physicians (AAFP). Please complete the evaluation to obtain CME credit.

Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program.

MOC credit is approved for this activity. Participants must complete entire self-assessment with a score of at least 80%.

Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.